A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis

BACKGROUND: Estimates of current global rabies mortality range from 26,000 to 59,000 deaths per annum. Although pre-exposure prophylaxis using inactivated rabies virus vaccines (IRVs) is effective, it requires two to three doses and is regarded as being too expensive and impractical for inclusion in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chuan, Dulal, Pawan, Zhou, Xiangyang, Xiang, Zhiquan, Goharriz, Hooman, Banyard, Ashley, Green, Nicky, Brunner, Livia, Ventura, Roland, Collin, Nicolas, Draper, Simon J., Hill, Adrian V. S., Ashfield, Rebecca, Fooks, Anthony R., Ertl, Hildegund C., Douglas, Alexander D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224154/
https://www.ncbi.nlm.nih.gov/pubmed/30372438
http://dx.doi.org/10.1371/journal.pntd.0006870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224154/
https://www.ncbi.nlm.nih.gov/pubmed/30372438
http://dx.doi.org/10.1371/journal.pntd.0006870

Ejemplares similares